ISSA launches a GLP-1 Weight Loss Support Training course to help fitness professionals safely guide clients using medications like Ozempic and Wegovy, addressing physical, emotional, and behavioral changes.

Warren Heffelfinger joins ISSA as the new CEO, aiming to expand global fitness and wellness education. Discover how ISSA plans to impact 100 million lives by 2030 under new leadership, with Andrew Wyant transitioning to Chief Growth Officer.